Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors (Q46522693)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors |
scientific article published in June 2005 |
Statements
1 reference
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors (English)
1 reference
Gregory Ayers
1 reference
Fadlo Khuri
1 reference
Sofia Agelaki
1 reference
Vali Papadimitrakopoulou
1 reference
Hai T Tran
1 reference
Merrill Kies
1 reference
Robert Gagel
1 reference
Ralph Zinner
1 reference
Edward Kim
1 reference
John Wright
1 reference
1 June 2005
1 reference
1 reference
11
1 reference
11
1 reference
4151-4159
1 reference
Identifiers
1 reference
1 reference